Pharmacokinetic–pharmacodynamic integration of danofloxacin in the calf
- 1 June 2003
- journal article
- Published by Elsevier in Research in Veterinary Science
- Vol. 74 (3) , 247-259
- https://doi.org/10.1016/s0034-5288(03)00005-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitisJournal of Antimicrobial Chemotherapy, 1997
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importanceResearch in Veterinary Science, 1993
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsisAntimicrobial Agents and Chemotherapy, 1993
- Clinical pharmacokinetics of parenterally administered danofloxacin in cattleJournal of Veterinary Pharmacology and Therapeutics, 1991
- Tissue‐chamber modeling systems ‐applications in veterinary medicineJournal of Veterinary Pharmacology and Therapeutics, 1989
- Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistanceAntimicrobial Agents and Chemotherapy, 1987
- Development of equine models of inflammation. The Ciba-Geigy Prize for Research in Animal HealthVeterinary Record, 1987